Paula Cramer
8PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki
|Jan 30, 2025
MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial.Moritz Fürstenau, Sandra Robrecht, Christof Schneider
|Nov 27, 2024
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial.Petra Langerbeins, Sandra Robrecht, Pascal Nieper
|Aug 30, 2024
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.Florian Simon, Rudy Ligtvoet, Sandra Robrecht
|May 17, 2024
Infections in patients with chronic lymphocytic leukemia treated with time limited targeted drug combinations.Petra Langerbeins, Adam Giza, Sandra Robrecht
|Apr 15, 2024
Reassessing the chronic lymphocytic leukemia International Prognostic Index in the era of targeted therapies.Petra Langerbeins, Adam Giza, Sandra Robrecht
Pageof 2
Frequent Collaborators
7 joint publications
Petra Langerbeins
6 joint publications
Moritz Fürstenau
5 joint publications
Florian Simon
4 joint publications
Othman Al-Sawaf
3 joint publications
Michael Hallek
2 joint publications
Sebastian Böttcher
2 joint publications
Nadine Kutsch
2 joint publications
Carsten Utoft Niemann
2 joint publications
Arnon P Kater
2 joint publications
Philipp Bernhard Staber
